Why anti-PD1/PDL1 therapy is so effective? Another piece in the puzzle

由 Marchetti, Antonio, Di Lorito, Alessia, Buttitta, Fiamma
發表在 J Thorac Dis (2017)

An innovative diagnostic strategy for the detection of rare molecular targets to select cancer patients for tumor-agnostic treatments

由 Marchetti, Antonio, Di Lorito, Alessia, Felicioni, Lara, Buttitta, Fiamma
發表在 Oncotarget (2019)

MicroRNAs derived from circulating exosomes as non-invasive biomarkers for screening and diagnose lung cancer

由 Cazzoli, Riccardo, Buttitta, Fiamma, Di Nicola, Marta, Malatesta, Sara, Marchetti, Antonio, Pass, Harvey I.
出版 2013

Extraordinary and prolonged erlotinib-induced clinical response in a patient with EGFR wild-type squamous lung cancer in third-line therapy: a case report

由 Gambale, Elisabetta, Carella, Consiglia, Amerio, Paolo, Buttitta, Fiamma, Patea, Rosa Lucia, Natoli, Clara, De Tursi, Michele
發表在 Int Med Case Rep J (2017)

Survival prediction of stage I lung adenocarcinomas by expression of 10 genes

由 Bianchi, Fabrizio, Nuciforo, Paolo, Vecchi, Manuela, Bernard, Loris, Tizzoni, Laura, Marchetti, Antonio, Buttitta, Fiamma, Felicioni, Lara, Nicassio, Francesco, Di Fiore, Pier Paolo
出版 2007

Mutational Profile of GNAQ (Q209) in Human Tumors

由 Lamba, Simona, Felicioni, Lara, Buttitta, Fiamma, Bleeker, Fonnet E., Malatesta, Sara, Corbo, Vincenzo, Scarpa, Aldo, Rodolfo, Monica, Knowles, Margaret, Frattini, Milo, Marchetti, Antonio, Bardelli, Alberto
出版 2009

Optimizing Single Agent Panitumumab Therapy in Pre-Treated Advanced Colorectal Cancer()()

由 Gasparini, Giampietro, Buttitta, Fiamma, D'Andrea, Mario Rosario, Tumolo, Salvatore, Buonadonna, Angela, Pavese, Ida, Cordio, Stefano, De Tursi, Michele, Mosconi, Stefania, Stumbo, Luciano, Felicioni, Lara, Marchetti, Antonio
發表在 Neoplasia (2014)

Complex Mutations & Subpopulations of Deletions at Exon 19 of EGFR in NSCLC Revealed by Next Generation Sequencing: Potential Clinical Implications

由 Marchetti, Antonio, Del Grammastro, Maela, Filice, Giampaolo, Felicioni, Lara, Rossi, Giulio, Graziano, Paolo, Sartori, Giuliana, Leone, Alvaro, Malatesta, Sara, Iacono, Michele, Guetti, Luigi, Viola, Patrizia, Mucilli, Felice, Cuccurullo, Franco, Buttitta, Fiamma
出版 2012

Assessment of EGFR Mutations in Circulating Tumor Cell Preparations from NSCLC Patients by Next Generation Sequencing: Toward a Real-Time Liquid Biopsy for Treatment

由 Marchetti, Antonio, Del Grammastro, Maela, Felicioni, Lara, Malatesta, Sara, Filice, Giampaolo, Centi, Irene, De Pas, Tommaso, Santoro, Armando, Chella, Antonio, Brandes, Alba Ariela, Venturino, Paola, Cuccurullo, Franco, Crinò, Lucio, Buttitta, Fiamma
出版 2014

MDM4 (MDMX) localizes at the mitochondria and facilitates the p53-mediated intrinsic-apoptotic pathway

由 Mancini, Francesca, Di Conza, Giusy, Pellegrino, Marsha, Rinaldo, Cinzia, Prodosmo, Andrea, Giglio, Simona, D'Agnano, Igea, Florenzano, Fulvio, Felicioni, Lara, Buttitta, Fiamma, Marchetti, Antonio, Sacchi, Ada, Pontecorvi, Alfredo, Soddu, Silvia, Moretti, Fabiola
出版 2009

Digital Pathology and PD-L1 Testing in Non Small Cell Lung Cancer: A Workshop Record

由 Pagni, Fabio, Malapelle, Umberto, Doglioni, Claudio, Fontanini, Gabriella, Fraggetta, Filippo, Graziano, Paolo, Marchetti, Antonio, Guerini Rocco, Elena, Pisapia, Pasquale, Vigliar, Elena V., Buttitta, Fiamma, Jaconi, Marta, Fusco, Nicola, Barberis, Massimo, Troncone, Giancarlo
發表在 Cancers (Basel) (2020)

Weekly alternate intensive regimen FIrB/FOx in metastatic colorectal cancer patients: an update from clinical practice

由 Cortellini, Alessio, Cannita, Katia, Parisi, Alessandro, Lanfiuti Baldi, Paola, Venditti, Olga, D’Orazio, Carla, Dal Mas, Antonella, Calvisi, Giuseppe, Giordano, Aldo V, Vicentini, Vincenzo, Vicentini, Roberto, Felicioni, Lara, Marchetti, Antonio, Buttitta, Fiamma, Russo, Antonio, Ficorella, Corrado
發表在 Onco Targets Ther (2019)

Clinical Implications of KRAS Mutations in Lung Cancer Patients Treated with Tyrosine Kinase Inhibitors: An Important Role for Mutations in Minor Clones

由 Marchetti, Antonio, Milella, Michele, Felicioni, Lara, Cappuzzo, Federico, Irtelli, Luciana, Del Grammastro, Maela, Sciarrotta, Mariagrazia, Malatesta, Sara, Nuzzo, Carmen, Finocchiaro, Giovanna, Perrucci, Bruno, Carlone, Donatella, Gelibter, Alain J, Ceribelli, Anna, Mezzetti, Andrea, Iacobelli, Stefano, Cognetti, Francesco, Buttitta, Fiamma
出版 2009

Increased MET Gene Copy Number Negatively Affects Survival of Surgically Resected Non–Small-Cell Lung Cancer Patients

由 Cappuzzo, Federico, Marchetti, Antonio, Skokan, Margaret, Rossi, Elisa, Gajapathy, Sujatha, Felicioni, Lara, del Grammastro, Maela, Sciarrotta, Maria Grazia, Buttitta, Fiamma, Incarbone, Matteo, Toschi, Luca, Finocchiaro, Giovanna, Destro, Annarita, Terracciano, Luigi, Roncalli, Massimo, Alloisio, Marco, Santoro, Armando, Varella-Garcia, Marileila
出版 2009

Early prediction of resistance to tyrosine kinase inhibitors by plasma monitoring of EGFR mutations in NSCLC: a new algorithm for patient selection and personalized treatment

由 Buttitta, Fiamma, Felicioni, Lara, Lorito, Alessia Di, Cortellini, Alessio, Irtelli, Luciana, Brocco, Davide, Marino, Pietro Di, Traisci, Donatella, D’Ostilio, Nicola, Paolo, Alessandra Di, Malorgio, Francesco, Assalone, Pasquale, Felice, Sonia Di, Fabbri, Francesca, Cianci, Giovanni, Tursi, Michele De, Marchetti, Antonio
發表在 Oncotarget (2020)

BRCA1/2 Molecular Assay for Ovarian Cancer Patients: A Survey through Italian Departments of Oncology and Molecular and Genomic Diagnostic Laboratories

由 Capoluongo, Ettore, La Verde, Nicla, Barberis, Massimo, Bella, Maria Angela, Buttitta, Fiamma, Carrera, Paola, Colombo, Nicoletta, Cortesi, Laura, Genuardi, Maurizio, Gion, Massimo, Guarneri, Valentina, Lorusso, Domenica, Marchetti, Antonio, Marchetti, Paolo, Normanno, Nicola, Pasini, Barbara, Pensabene, Matilde, Pignata, Sandro, Radice, Paolo, Ricevuto, Enrico, Sapino, Anna, Tagliaferri, Pierosandro, Tassone, Pierfrancesco, Trevisiol, Chiara, Truini, Mauro, Varesco, Liliana, Russo, Antonio, Gori, Stefania
發表在 Diagnostics (Basel) (2019)

The Hippo effector YAP promotes resistance to RAF- and MEK-targeted cancer therapies

由 Lin, Luping, Sabnis, Amit J, Chan, Elton, Olivas, Victor, Cade, Lindsay, Pazarentzos, Evangelos, Asthana, Saurabh, Neel, Dana, Yan, Jenny Jiacheng, Lu, Xinyuan, Pham, Luu, Wang, Mingxue M, Karachaliou, Niki, Cao, Maria Gonzalez, Manzano, Jose Luis, Ramirez, Jose Luis, Torres, Jose Miguel Sanchez, Buttitta, Fiamma, Rudin, Charles M, Collisson, Eric A, Algazi, Alain, Robinson, Eric, Osman, Iman, Muñoz-Couselo, Eva, Cortes, Javier, Frederick, Dennie T, Cooper, Zachary A, McMahon, Martin, Marchetti, Antonio, Rosell, Rafael, Flaherty, Keith T, Wargo, Jennifer A, Bivona, Trever G
發表在 Nat Genet (2015)